Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1998
12/20/1998CA2241117A1 Herbal anti-diabetic therapeutic product
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056898A2 Human peroxisomal thioesterase
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056814A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
12/17/1998WO1998056788A1 Imidazolyl-cyclic acetals
12/17/1998WO1998056787A1 4-Phenylpiperidine compounds
12/17/1998WO1998056406A1 Stable insulin formulations
12/17/1998WO1998056378A1 Novel niddm regimen
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998DE19725391A1 Verfahren zur Herstellung von Arzneimittel, enthaltend HMG-CoA-Reduktase-Inhibitoren A process for the production of medicaments comprising HMG-CoA reductase inhibitors
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/16/1998EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0884321A1 Ascorbic acid 2-phosphate zinc salt and process for manufacturing the same
12/16/1998EP0884053A1 Stable insulin formulations
12/16/1998EP0884052A1 Cartilage/bone inducing materials for reparation
12/16/1998EP0884050A1 Use of 3,4-dihydroxy-2-hydroxymethylpyrrolidine for the treatment of diabetes
12/16/1998EP0883406A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
12/16/1998EP0883404A1 Combination therapy for osteoporosis
12/16/1998EP0883401A1 At1 receptor antagonist for the stimulation of apoptosis
12/16/1998EP0696585B1 Novel bisoxadiazolidine derivative
12/16/1998CN1202107A Selective 'beta'3 adrenergic agonists
12/16/1998CN1202106A Selective 'beta'3 adrenergic agonists
12/16/1998CN1202105A 2-alkylpyrrolidines
12/16/1998CN1041203C Preparation of pyrazolopyridine compound
12/15/1998US5849930 Pyrazolidine derivative radical scavenger brain-infarction depressant and brain-edema depressant
12/15/1998US5849865 Peptides for altering bone resorption, angiogenesis and restenosis
12/15/1998US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998US5849787 Hypercholesterolemia therapeutic agent
12/15/1998US5849781 Tricyclic amides
12/15/1998US5849751 Amides and sulphonamides of benzylamines having heterocyclic substituents
12/15/1998US5849749 6-(hydroxymethyl-ethyl)pyridines
12/15/1998US5849740 Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
12/15/1998US5849739 5-arylindole derivatives
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849708 Promotion of eating behavior
12/15/1998US5849584 Cell cultures of and cells culturing method for nontransformed parotid cells
12/15/1998US5849535 Human growth hormone variants
12/15/1998US5849506 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/15/1998US5849485 Liver enriched transcription factor
12/15/1998US5849283 Human interleukin-6 receptor antagonists
12/15/1998CA2101274C Microbial oil mixtures and uses thereof
12/15/1998CA1340246C Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and athersclerosis
12/13/1998CA2240312A1 .beta.-adrenergic agonists to reduce a wasting condition
12/11/1998CA2233584A1 7tm receptor hlwar77
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055475A1 Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
12/10/1998WO1998055144A1 Methods for treating obesity
12/10/1998WO1998055139A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998WO1998055123A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055122A1 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
12/10/1998WO1998055121A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
12/10/1998WO1998054981A1 Method for administering viable microorganism composition for poultry
12/10/1998WO1998035967A3 Biazacyclic crf antagonists
12/10/1998CA2333352A1 Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione
12/10/1998CA2293504A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998CA2292880A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/10/1998CA2283319A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
12/10/1998CA2234411A1 Novel compounds
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998EP0882718A1 Benzimidazole derivatives
12/09/1998EP0882707A1 Novel tricyclic compounds and drug compositions containing the same
12/09/1998EP0882450A2 Cholesterol-lowering composition comprising coenzyme Q
12/09/1998EP0882029A1 Heterocyclic derivatives as antidiabetic and antiobesity agents
12/09/1998EP0810866A4 Use of acid-sensitive organo- transition metal compounds in cancer treatment
12/09/1998CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate
12/09/1998CN1201455A Process and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy] ethylamino)-3-phenoxy-2(S)-ol
12/09/1998CN1201397A Improved prescription for steroid compound administration
12/09/1998CN1201392A Pentacyclic compounds, intermediates, preparation process, compositions and methods thereof
12/09/1998CN1200933A Traditional Chinese medicinal composition with reducing-blood-sugar activity
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5847000 Fatty acid derivatives
12/08/1998US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998US5846968 N-substituted azaheterocyclic carboxylic acids and esters
12/08/1998US5846966 Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
12/08/1998US5846962 Anti-obesity agents
12/08/1998CA2026671C 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
12/08/1998CA1340171C Aqueous solution conataing fat-soluble vitamin k
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
12/03/1998WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998WO1998054184A1 1,6-naphthyridine anti-convulsants
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054166A1 A new salt
12/03/1998WO1998054153A1 Novel cyclic diamine compounds and medicine containing the same
12/03/1998WO1998054138A1 Novel orally active iron (iii) chelators
12/03/1998WO1998053847A1 Transdermal delivery system
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053824A1 Novel process
12/03/1998WO1998053823A1 5-HT1A AND 5-HT1Dα ANTAGONISTS